Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy
Year: 2013
Type: article
Study design: Observational Study
Source: Inflammatory Bowel Diseases
Authors: Martine De Vos, Edouard J. Louis, Jørgen Jahnsen, Jo G.P. Vandervoort, Maja Noman, Olivier Dewit, Geert R. DʼHaens, Denis Franchimont, Filip J. Baert, Roald A. Torp, Magne Henriksen, Philippe M.R. Potvin, Philippe P. Van Hootegem, Pieter M. Hindryckx, Tom G. Moreels, Arnaud Collard, Lars Normann Karlsen, Eirik Kittang, Guy Lambrecht, Tore Grimstad, Jonas Koch, Idar Lygren, Jean-Claude R.J. Coche, Fazia Mana, André Van Gossum, Jacques Belaiche, Mike R. Cool, Fernand Fontaine, Jean-Marc G. Maisin, Vinciane Muls, Bart Neuville, Dirk A. J. Staessen, Gert A. Van Assche, Thomas de Lange, Inger Camilla Solberg, Bert J.K. Vander Cruyssen, Severine A.R.A. Vermeire
Institutions: Ghent University Hospital, Centre Hospitalier Universitaire de Liège, Oslo University Hospital, Onze Lieve Vrouwziekenhuis Hospital, Universitair Ziekenhuis Leuven, Cliniques Universitaires Saint-Luc, Amsterdam UMC Location University of Amsterdam, Imelda Hospital, Erasmus Hospital, Innlandet Hospital Trust, Inland Hospital, Østfold Hospital Trust, AZ Rivierenland, AZ Sint-Lucas, Antwerp University Hospital, Clinique Saint-Joseph, Stavanger University Hospital, Sykehuset i Vestfold, Damiaan Dicht bij het leven, Vestre Viken Hospital Trust, Clinique Saint Pierre, Universitair Ziekenhuis Brussel, Centre Hospitalier Universitaire de Saint-Pierre, Ziekenhuis Oost-Limburg
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Keywords: fecal calprotectin, ulcerative colitis
Open Access status: closed
OpenAlex ID: W2052776464
